Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Med Sci 2021; 18(1):150-156. doi:10.7150/ijms.49328 This issue Cite

Research Paper

MiR-125b promotes migration and invasion by targeting the vitamin D receptor in renal cell carcinoma

Xiyuan He1, Shangfan Liao1, Dongming Lu1, Fabiao Zhang1, Yingming Sun2, Yongyang Wu1✉

1. Department of Urology, Affiliated Sanming First Hospital of Fujian Medicine University, Sanming, Fujian 365100, China.
2. Department of Medical and Radiation Oncology, Affiliated Sanming First Hospital of Fujian Medicine University, Sanming, Fujian 365100, China.

✉ Corresponding author: Yongyang Wu, M.D., Ph.D., Department of Urology, Affiliated Sanming First Hospital of Fujian Medicine University, Sanming, Fujian 365100, China, E-mail: wuyyfjedu.cn.

Citation:
He X, Liao S, Lu D, Zhang F, Sun Y, Wu Y. MiR-125b promotes migration and invasion by targeting the vitamin D receptor in renal cell carcinoma. Int J Med Sci 2021; 18(1):150-156. doi:10.7150/ijms.49328. https://www.medsci.org/v18p0150.htm
Other styles

File import instruction

Abstract

Purpose: To investigate the expression of miR-125b and vitamin D receptor (VDR) in renal cell carcinoma (RCC) and assess the biological function of miR-125b in RCC.

Methods: We used quantitative real-time polymerase chain reaction (RT-PCR) to detect the expression of nucleic acids and western blotting to analyze the protein abundance in RCC cell lines. MiR-125b mimic and inhibitor were employed to investigate the function and behavior of miR-125b in RCC cell lines. The relationship between miR-125 and VDR was verified using luciferase assays.

Results: Overexpression of miR-125b promoted migration and invasion and prevent cell apoptosis in ACHN cells. In contrast, miR-125b deficiency suppressed migration and invasion and induced cell apoptosis in 786-O cells. Luciferase assays indicated the interaction between miR-125b and VDR. In collected samples, miR-125b was significantly higher in RCC tissues and negatively correlated to VDR (r=-0.444, p=0.04).

Conclusion: MiR-125b displays an oncogene profile in RCC, patients with high expression of miR-125b should be a more frequent follow-up. MiR-125B may be a potential therapeutic target for RCC.

Keywords: Renal Cell Carcinoma, Vitamin D Receptor, MicroRNA, MiR-125b

Citation styles

APA
He, X., Liao, S., Lu, D., Zhang, F., Sun, Y., Wu, Y. (2021). MiR-125b promotes migration and invasion by targeting the vitamin D receptor in renal cell carcinoma. International Journal of Medical Sciences, 18(1), 150-156. https://doi.org/10.7150/ijms.49328.

ACS
He, X.; Liao, S.; Lu, D.; Zhang, F.; Sun, Y.; Wu, Y. MiR-125b promotes migration and invasion by targeting the vitamin D receptor in renal cell carcinoma. Int. J. Med. Sci. 2021, 18 (1), 150-156. DOI: 10.7150/ijms.49328.

NLM
He X, Liao S, Lu D, Zhang F, Sun Y, Wu Y. MiR-125b promotes migration and invasion by targeting the vitamin D receptor in renal cell carcinoma. Int J Med Sci 2021; 18(1):150-156. doi:10.7150/ijms.49328. https://www.medsci.org/v18p0150.htm

CSE
He X, Liao S, Lu D, Zhang F, Sun Y, Wu Y. 2021. MiR-125b promotes migration and invasion by targeting the vitamin D receptor in renal cell carcinoma. Int J Med Sci. 18(1):150-156.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.

©2023 Ivyspring International Publisher. Terms of use